We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effect of Spondias Mombin Ethanolic Extracts on Serum Lipid Profile and Serum Glucose Levels on Streptozotocin - Induced Diabetes Male Albino Rats.
- Authors
OKEREKE, STANLEY CHUKWUMA; IKPEAZU, OKEZIE VICTOR; NWAOGWUGWU, CALEB JOEL; UHEGBU, FRIDAY OBINWA; AKARA, EMMANUEL; NOSIRI, IJEOMA CHIDI; EZEKWE, AHAMEFULA SUNDAY; AGHALIBE, CHRISTOPHER UGOCHUKWU; CHINEDU, AGUWAMBA
- Abstract
This study was carried out to investigate the effects of Spondias mombin (leaf, root, seed and stem bark) ethanolic extract on serum lipid profile and serum glucose levels of strepzotocin - induced diabetic male albino rats. Thirty-five assumed healthy albino rats (8 weeks old) weighing between 66g and 84g were collected from the Animal house of Department of Biochemistry, Abia State University, Uturu, Nigeria. The animals were randomly placed into 7 groups. Group 1: Served as normal control, 2 served as diabetic control group were not treated, 3 served as diabetic group treated with a standard drug glycinorm at 80mg/kg body weight, 4 served as diabetic group and were treated with ethanolic extracts of Spondias mombin leaf at 500mg/kg body weight, 5 diabetic group treated with ethanolic extracts of Spondias mombin stem bark at 500mg/kg body weight, 6 diabetic group treated with ethanolic extracts of Spondias mombin root at 500mg/kg body weight and 7 diabetic group treated with ethanolic extracts of Spondias mombin seed at 500mg/kg body weight by oral administration respectively. Diabetes was induced in albino rats by intraperitoneal injection of strepzotocin at a single dose of 120 mg/kg body weight into group 3 to 7 and were subsequently treated with ethanolic extracts of the different parts of Spondias mombin for a period of 28 days. Glucose levels were measured on days 0 7, 14, 21, and day 28. Animal were sacrificed on the 29th day and serum lipid profile and serum glucose levels measured using standard laboratory methods. The administration of streptozotocin significantly increased (p<0.05) the levels of cholesterol, HDL, Triacylglycerol, LDL and VLDL respectively when compared to the normal control (p<0.05). Standard drug (glycinorm, 80mg/kg) and Spondias mombin extracts decreased the concentration of these macromolecules. There was a general decreasing trend in the mean values of lowdensity lipoprotein levels across the groups, however cholesterol, HDL LDL and Tricylglycerol shows significant decrease across all t1997he groups when compare with group 2. The ethanolic extract of Spondias mombin (leaf, seed, stem bark and root) decreased (p<0.05) significantly serum glucose levels in the diabetic rats. Spondias mombin extracts may be a potent antidiabetic agent. This provides claims that the plant (stem bark, leaves, root and seeds) was able to ameliorate abnormalities associated with Diabetes Mellitus, hence used in the management of diabetes in alternative medicine practice. It also shows the plant possess antilipidemic and hypoglycemic properties. This study suggests that ethanolic extracts of Spondias mombin plant parts have active components that are capable of lowering serum glucose level and serum lipid profile and this might be useful in the management of diabetes mellitus and cardiovascular diseases.
- Subjects
SPONDIAS; PLANT extracts; BLOOD lipids; STREPTOZOTOCIN; BLOOD sugar monitoring; HYPOGLYCEMIC agents
- Publication
International Journal of Pharmaceutical Research (09752366), 2021, Vol 13, Issue 2, p2387
- ISSN
0975-2366
- Publication type
Article
- DOI
10.31838/ijpr/2021.13.02.296